Eledon Pharmaceuticals Inc
NASDAQ:ELDN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
|
US |
|
C
|
Chalice Mining Ltd
XMUN:C8U
|
AU |
|
B
|
Berli Jucker PCL
SET:BJC
|
TH |
|
Takashimaya Co Ltd
F:DC9
|
JP |
|
E
|
Exact Sciences Corp
F:EXK
|
US |
|
A
|
AES Corp
XMUN:AES
|
US |
|
ITAB Shop Concept AB
F:29I0
|
SE |
|
E
|
Edison International
XMUN:EIX
|
US |
|
B&C Speakers SpA
F:37B
|
IT |
|
Sable Offshore Corp
NYSE:SOC
|
US |
|
C
|
Collins Foods Ltd
F:6CF
|
AU |
|
Maxlinear Inc
NASDAQ:MXL
|
US |
Intrinsic Value
Is ELDN undervalued or overvalued?
See the intrinsic value estimate for Eledon Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Eledon Pharmaceuticals Does
Eledon Pharmaceuticals is a clinical-stage drug company focused on medicines that calm the immune system. Its lead programs center on tegoprubart, an antibody designed to block a key immune signal called CD40L. The goal is to help patients who receive organ transplants or who live with autoimmune diseases by reducing harmful immune attacks without shutting the immune system down completely.
- Headquarters
- United States of America US
- Employees
- 33
- IPO date
- Sep 17, 2014
Revenue & Expenses Breakdown
Eledon Pharmaceuticals Inc
Earnings Waterfall
Eledon Pharmaceuticals Inc
The intrinsic value for Eledon Pharmaceuticals Inc (ELDN) under the Base Case is hidden USD.
Compared with the current market price of 3.15 USD, the stock appears hidden.